Skip to main content
SpringerLink
Log in

Effect of vitamin B6 on the serum concentration of pituitary hormones in normal humans and under pathologic conditions

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The effect of the acute intravenous administration of B6(300 mg pyridoxine chloride and 10 mg pyridoxal 5 — phosphate) on the circulating levels of pituitary hormones was investigated in humans under normal and pathologic conditions. In normal subjects maximal changes expressed as per cent of the basal levels were as follows: 52% suppression of prolactin (PRL) at 90 minutes, 18% of TSH at 90 minutes and 315% stimulation of GH at 30 minutes. LH was also mildly suppressed (38%) at 60 minutes but there were no appreciable changes in serum FSH and Cortisol. The effect of Beon PRL and GH release was abolished after 3 day pretreatment with sulpiride; this finding suggests a dopaminergic mediation. In hypothalamo-pituitary diseases the response to Be was found altered: the inhibition of serum PRL was diminished in normo- or hyperprolactinemic women with galactorrhea and disturbed menses but without X-ray evidence of pituitary tumor. When PRL or GH secreting adenomas were present, the responses of PRL and GH to Be were absent or paradoxical. Our observations support the hypothesis that in normal subjects Be activates hypothalamic aromatic-L-aminoacid-decarboxylase with a consequent increase of dopamine concentration. The lack of response to Be observed in hypothalamo-pituitary disorders might be attributed either to an abnormal response of the pituitary to dopamine or to a reduced ability of the coenzyme to promote the synthesis of this neurotransmitter.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Coursin D.B. Vitamin B6 and brain functions in animals and man. Ann. N.Y. Acad. Sci., 166: 7, 1969.

    Article  PubMed  CAS  Google Scholar 

  2. Driskell J.A., Lee Chuang S.L. Relationship between glutamnic decarboxylase activities in brains, and the vitamin B6 requirement of male rats. J. Nutr. 104: 1657, 1974.

    PubMed  CAS  Google Scholar 

  3. Driskell J.P., Strickland L.A., Poon L.H., Foshee D.P. The vitamin B6 requirement of the male rat as determined by behavioral patterns, brain pyridoxal phosphate and nucleic acid composition and erythrocyte alanine amino transferase activity. J. Nutr. 103: 670, 1973.

    PubMed  CAS  Google Scholar 

  4. Driskell J.A., Foshee D.P. Behavioral patterns and brain nucleic acid and pyridoxal phosphate contents of male rat progeny from vitamin B6 repleted dams. J. Nutr. 704:810, 1974.

    Google Scholar 

  5. Wiss O., Weber F. Biochemical pathology of vitamin B6 deficiency. Vitam. Horm. 22: 495, 1964.

    Article  PubMed  CAS  Google Scholar 

  6. Kamberi I.A., Mical R.S., Porter J.C. Prolactin inhibiting activity in hypophyseal stalk blood and elevation by dopamine. Experentia 26: 1150, 1970.

    Article  CAS  Google Scholar 

  7. Kordon C, Glowinsky J. Role of brain cathecolamines in the control of anterior pituitary function. In: Martini L, Meites J. (Eds.), Neurochemical aspects of hypothalamic function. Academic Press, New York, 1970, p. 85.

    Google Scholar 

  8. Kamberi I.A., Mical R.S., Porter J.C. Effects of melatonin and serotonin on the release of FSH and prolactin. Endocrinology 88: 1288, 1971.

    Article  PubMed  CAS  Google Scholar 

  9. Imura H., Nakai Y., Yoshimi T. Effect of 5-hydroxytryptophan (5 HPT) on growth hormone and ACTH release in man. J. Clin. Endocrinol. Metab. 36: 204, 1973.

    Article  PubMed  CAS  Google Scholar 

  10. Makris A., Gershoff S.N. Growth hormone levels in vitamin B6 deficient rats. Horm. Metab. Res. 5: 457, 1973.

    Article  PubMed  CAS  Google Scholar 

  11. Huber A.M., Gershoff S.N. Some effects of vitamin B6 deficiency on rat pituitary glands. J. Nutr. 87: 407, 1965.

    PubMed  CAS  Google Scholar 

  12. Rodda R.A. Bone growth change in pyridoxine deficient rats. J. Pathol. 117: 131, 1975.

    Article  PubMed  CAS  Google Scholar 

  13. Foukas M.D. An antilactogenic effect of pyridoxine. J. Obstet. Gynaecol. Br. Commonw. 30: 718, 1973.

    Article  Google Scholar 

  14. Bigazzi M., Ferraro S., Ronga R., Zurli A. The use of pyridoxine as a test of diencephalous-pituitary function In: Butturini U., Valenti G. (Eds.) Patologia espansiva ipofisaria. Pacini, Pisa, 1977, p. 291.

    Google Scholar 

  15. Marcus R.G. Suppression of lactation with high doses of pyridoxine. S. Afr. Med. J. 49:2155, 1975.

    PubMed  CAS  Google Scholar 

  16. Mac Donald H.N. The failure of pyridoxine in suppression of puerperal lactation. Br. J. Obstet. Gynaecol. 83: 54, 1976.

    Article  CAS  Google Scholar 

  17. Canales E.S., Soria J., Zarate A., Mason M., Molina M. The influence of pyridoxine on prolactin secretion and milk production in women. Br. J. Obstet. Gynaecol. 83: 387, 1976.

    Article  PubMed  CAS  Google Scholar 

  18. Mcintosh E.N. Treatment of women with the galactorrhea-amenorrhea syndrome with pyridoxine (vit. B6). J. Clin. Endocrinol. Metab. 42: 1192, 1976.

    Article  PubMed  CAS  Google Scholar 

  19. Delitala G., Masala A., Alagna S., Devilla L. Effect of pyridoxine on human hypophyseal thropic hormone release: a possible stimulation of hypothalamic dopaminergic pathway. J. Clin. Endocrinol. Metab. 42: 603, 1976.

    Article  PubMed  CAS  Google Scholar 

  20. Delitala G., Rovasio P., Lotti G. Suppression of thyrotropin (TSH) and prolactin (PRL) release by pyridoxine in chronic primary hypothyroidism. J. Clin. Endocrinol. Metab. 45: 1019, 1977.

    Article  PubMed  CAS  Google Scholar 

  21. Tolis G., Laliberte’ R., Guyda H., Naftolin F. Ineffectiveness of Pyridoxine (Be) to after secretion of growth hormone and prolactin and absence of therapeu tic effects on galactorrhea-amenorrhea syndromes. J. Clin. Endocrinol. Metab. 44: 1197, 1977.

    Article  PubMed  CAS  Google Scholar 

  22. Delitala G., Masala A., Alagna S., Devilla L. Plasma prolactin response to pyridoxine in the galactorrhea-amenorrhea syndrome. IRCS Med. Sci. 3: 525, 1975.

    Google Scholar 

  23. Lehtovirta P., Rauta T., Seppälä M. Pyridoxine treatment of galactorrhea-amenorrhea syndromes. Acta Endocrinol. (Kbh.) 87: 682, 1978.

    CAS  Google Scholar 

  24. Spiegel A.M., Rosen S.W., Weintraub B.D., Marynick S.M. Effect of intravenous pyridoxine on plasma prolactin in hyperprolactinemic subjects. J. Clin. Endocrinol. Metab. 46: 686, 1978.

    Article  PubMed  CAS  Google Scholar 

  25. Robins E., Robins M.J., Croninger A.B., Moses S.G., Spencer S.J., Mudgens R.W. Brain amines and their synthesis in man. Biochemistry 1: 240, 1976.

    Google Scholar 

  26. Hsu T.H., Bianchine J.R., Preziosi J., Messina F.S., Effect of pyridoxine on levodopa metabolism in normal and parkinsonian subjects. Proc. Soc. Exp. Biol. Med. 143: 578, 1973.

    Article  PubMed  CAS  Google Scholar 

  27. Carter A.B. Pyridoxine and parkinsonism. Br. Med. J. 1:236, 1973.

    Article  Google Scholar 

  28. Mims R.B., Scott C.L. Modebe O., Bethune J.E. Inhibition of L-dopa induced growth hormone stimulation by pyridoxine and chlorpromazine. J. Clin. Endocrinol. Metab. 40: 256, 1975.

    Article  PubMed  CAS  Google Scholar 

  29. Harris A.C., Smith M.S., Alex S., Salhanick H.A., Vagenakis A.G., Braverman L.E. Pyridoxine (Bo) — induced inhibition of prolactin release in the female rat. Endocrinology 102: 362, 1978.

    Article  PubMed  CAS  Google Scholar 

  30. Malarkey W.B., Jacobs L.S., Daughaday W.H. L-dopa suppression of prolactin in non puerperal galactorrhea. N. Engl. J. Med. 285: 1160, 1971.

    Article  PubMed  CAS  Google Scholar 

  31. Turkington R.W. Inhibition of prolactin secretion and successful! therapy of the Forbes-Albright syndrome with L-dopa. J. Clin. Endocrinol. Metab. 34: 306, 1972.

    Article  PubMed  CAS  Google Scholar 

  32. Liuzzi A., Chiodini P.G., Botalla L, Cremascioli G., Silvestrini F. Inhibitory effect of L-dopa on GH release in acromegalic patients. J. Clin. Endocrinol. Metab. 35: 941, 1972.

    Article  PubMed  CAS  Google Scholar 

  33. Caufriez A., Robyn C. Pathophysiology of human prolactin secretion with special reference to prolactin secreting pituitary adenomas and isolated galactorrhea. In: Crosignani P.G., Robyn C. (Eds.), Prolactin and human reproduction. Academic Press, London 1977, p. 179.

    Google Scholar 

  34. Liuzzi A., Chiodini P.G., Botalla L., Cremascioli G., Müller E.E., Silvestrini F. Decreased plasma growth hormone (GH) levels in acromegalics following CB-154 administration. J. Clin. Endocrinol. Metab. 38: 910, 1974.

    Article  PubMed  CAS  Google Scholar 

  35. Azuma K. Apparent deficiency of vitamin B6 in typical individuals who commonly serve as normals controls. Res. Commun. Chem. Pathol. Pharmacol. 14: 343, 1976.

    PubMed  CAS  Google Scholar 

  36. Rose CS. Age differences in Vit. B6 status of 617 men. Ann. J. Clin. Nutr. 29: 847, 1976.

    CAS  Google Scholar 

  37. Adams P.V., Wynn V., Rose D.P., Seed M., Folkard J., Strong R. Effect of pyridoxine hydrochloride (vitamin B6) upon depression associated with oral contraception. Lancet 1:897, 1973.

    Article  Google Scholar 

  38. Tant D. Megaloblastic anaemia due to pyridoxine deficiency associated with prolonged ingestion of an oestrogen-containing oral contraceptive. Br. Med. J. 2:979, 1976.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  39. Driskell J.A. Vitamin B6 status of young men, women, and women using oral contraceptive. J. Lab. Clin. Med. 87:813, 1976.

    PubMed  CAS  Google Scholar 

  40. Prasad A.S., Lei K.Y., Mochissi K.S., Stryken J.G., Oberleas D. Effect of oral contraceptive on nutrients: III vitamin B6, B12, and folic acid. Am. J. Obstet. Gynaecol. 125: 1603, 1976.

    Google Scholar 

  41. Hasples A.A. Estrogens and vit. B6 Front. Horm. Res. 3: 199, 1975.

    Google Scholar 

  42. Howard L, Oldemorf M., Chu R. Pyridoxine deficiency: another potential signalof the jejunal ileal — bypass procedure. N. Engl. J. Med. 295: 733, 1976.

    PubMed  CAS  Google Scholar 

  43. Mitchell D., Wagner C, Stone W.J., Wilinson G.R., Schenfer S. Abnormal regulation of plasma pyridoxal 5-phosphate in patients with liver diseases. Gastroenterology 71: 1043, 1976.

    PubMed  CAS  Google Scholar 

  44. Ooelingh Benmuik H.J., Schreurs W.H. Improvement of oral tolerance in gestational diabetes by pyridoxine. Br. Med. J. 3: 13, 1975.

    Article  Google Scholar 

  45. Nobbs B.T. Pyridoxal phosphate status in clinical depression. Lancet 1: 405, 1974.

    Article  PubMed  CAS  Google Scholar 

  46. Mason D.Y., Emerson P.M. Primary acquired sideroblastic anaemia: response to treatment with pyridoxal 5-phosphate. Br. Med. J. 1:389, 1973.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  47. Hines J.D., Cowan D.H. Studies on the pathogenesis of alcohol-induced sideroblastic bone-marrow abnormalities. N. Engl. J. Med. 283:441, 1970.

    Article  PubMed  CAS  Google Scholar 

  48. Greengard O., Gordon M. The cofactor mediated regulation of apoenzyme levels in animal tissues. J. Biol. Chem. 238: 3708, 1964.

    Google Scholar 

  49. Rose D.P., Strong R., Folkard J., Adams P.W. Erythrocyte aminotransferase activities in women using oral contraceptives, and the effect of vit. B6 supplementation. Am. J. Clin. Nutr. 26: 48, 1973.

    PubMed  CAS  Google Scholar 

  50. Davis V.E. Effect of cortisone and tyroxine on aromatic aminoacid decarboxylation. Endocrinology 72: 33, 1963.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radioimmunology Section, Prosperius Institute, Firenze, Endocrine Unit, Poggiosecco Hospital, I.N.R.C.A., Firenze and Department of Obstretrics and Gynecology, University of Firenze, Via Incontri, 30, Florence, Italy

    M. Bigazzi, S. Ferraro, R. Ronga, G. Scarselli, V. Bruni & A. L. Olivotti

Authors
  1. M. Bigazzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Ferraro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Ronga
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Scarselli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V. Bruni
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. L. Olivotti
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bigazzi, M., Ferraro, S., Ronga, R. et al. Effect of vitamin B6 on the serum concentration of pituitary hormones in normal humans and under pathologic conditions. J Endocrinol Invest 2, 117–124 (1979). https://doi.org/10.1007/BF03349302

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349302

Key-words

Search

Navigation